SCHEMBL5880381

SCHEMBL5880381

CCOC(=O)CCc1ccccc1SC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 3/20 0.61
▸ CYP4A11 Q02928 3/20 0.61
▸ ALDH1A1 P00352 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MAPT P10636 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA4 P22748 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ ACHE P22303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23665897 0.85 CYP4F2 (0.65) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL69660 0.82 CYP4F2 (0.86) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL3110101 0.80 CA12 (0.51) ALDH1A1SMN1; SMN2CA12CA1CA2
SCHEMBL10585673 0.79 CA12 (0.50) CA12CA1CA2CA4CA7
SCHEMBL28008696 0.79 CYP4F2 (0.81) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL7509868 0.78 CA12 (0.46) CYP4F2CYP4A11ALDH1A1CYP2D6CA12
SCHEMBL13948404 0.78 CYP4F2 (0.73) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL12419024 0.77 CA12 (0.55) ALDH1A1MAPTCA12CA1CA2
SCHEMBL18455674 0.76 CYP4F2 (0.71) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL22098182 0.76 CYP4F2 (1.00) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7141694-B2 Enzymatic resolution of aryl and thio-substituted acids BRISTOL-MYERS SQUIBB COMPANY (US) 2006-11-28 — — US disclosed
US-7026143-B2 Enzymatic resolution of aryl and thio-substituted acids BRISTOL-MYERS SQUIBB COMPANY (US) 2006-04-11 — — US disclosed
US-20040077061-A1 Enzymatic resolution of aryl and thio-substituted acids ZHU JINGYANG (US) 2004-04-22 — — US disclosed
US-20040072310-A1 Enzymatic resolution of aryl and thio-substituted acids ZHU JINGYANG (US) 2004-04-15 — — US disclosed
US-6620600-B2 Monitoring preferential compounds in racemic; obtain enantiomer, incubate with racemic mix, hydrolyze mix, recover preferential compound BRISTOL-MYERS SQUIBB CO. 2003-09-16 — — US disclosed
EP-1328655-A2 ENZYMATIC RESOLUTION OF ARYL- AND THIO-SUBSTITUTED ACIDS Bristol-Myers Squibb Company (US) 2003-07-23 — — EP disclosed
US-20020061565-A1 Monitoring preferential compounds in racemic; obtain enantiomer, incubate with racemic mix, hydrolyze mix, recover preferential compound BRISTOL-MYERS SQUIBB COMPANY 2002-05-23 — — US disclosed
WO-2002022849-A2 ENZYMATIC RESOLUTION OF ARYL- AND THIO-SUBSTITUTED ACIDS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-03-21 — — WO disclosed
Send feedback